AI assistant
Merck & Co., Inc. — Director's Dealing 2019
Mar 28, 2019
284_dirs_2019-03-28_8682094e-b705-4025-8cce-0e39c888dfd7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-03-18
Reporting Person: Fleming Michael (SVP Chief Ethics & Com Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1345.0000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $ | 2021-05-04 | Common Stock (2078.0000) | Direct | |
| Restricted Stock Unit | $ | 2020-05-05 | Common Stock (1290.0000) | Direct | |
| Restricted Stock Unit | $ | 2019-05-10 | Common Stock (1509.0000) | Direct | |
| Stock Option (right to buy) | $54.6800 | 2026-05-09 | Common Stock (8676.0000) | Direct | |
| Stock Option (right to buy) | $57.7500 | 2028-05-03 | Common Stock (14638.0000) | Direct | |
| Stock Option (right to buy) | $58.2200 | 2024-05-01 | Common Stock (1004.0000) | Direct | |
| Stock Option (right to buy) | $63.9700 | 2027-05-04 | Common Stock (11769.0000) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.
F5: The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F6: The option became exercisable in equal installments on 5/2/2015, 5/2/2016 and 5/2/2017.
F7: The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.